ARVN - Arvinas, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ARVN (1655759)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
11 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2025-03-18
ARVNBerkowitz NoahChief Medical OfficerS - Sale$8.59-8,658110,023-7%-$74,372
2025-02-24
ARVNLoomis David KChief Accounting OfficerS - Sale$16.75-1,21418,863-6%-$20,335
2025-02-24
ARVNCacace Angela MChief Scientific OfficerS - Sale$16.70-4,20797,231-4%-$70,238
2025-02-24
ARVNTaylor IanPres, R, DS - Sale$16.71-9,020159,121-5%-$150,752
2025-02-24
ARVNHouston John GPres, CEOS - Sale$16.72-31,3381,157,480-3%-$523,881
M
2023-11-08
ARVNLoomis David KChief Accounting OfficerS - Sale$22.39-4608,040-5%-$10,301
D
2024-02-23
ARVNHouston John GPres, CEOS - Sale+OE$47.05-5,1961,036,6810%-$244,472
2024-02-23
ARVNCassidy Sean ACFOS - Sale$47.05-1,702181,916-1%-$80,079
D
2024-02-23
ARVNPeck RonaldChief Medical OfficerS - Sale+OE$47.05-1,69967,516-2%-$79,938
D
2024-02-23
ARVNTaylor IanChief Scientific OfficerS - Sale+OE$47.05-1,701147,522-1%-$80,032
D
2023-08-11
ARVNPeck RonaldChief Medical OfficerS - Sale+OE$24.39-1,32429,965-4%-$32,289

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top